Ignite Creation Date:
2025-12-24 @ 6:30 PM
Ignite Modification Date:
2026-01-02 @ 7:49 AM
Study NCT ID:
NCT01812668
Status:
COMPLETED
Last Update Posted:
2021-08-05
First Post:
2013-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03
Start Date Type:
None
Primary Completion Date:
2019-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-18
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-14
First Submit QC Date:
None
Study First Post Date:
2013-03-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-02-26
Results First Submit QC Date:
None
Results First Post Date:
2021-03-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-03
Last Update Post Date:
2021-08-05
Last Update Post Date Type:
ACTUAL